Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
472,561
-
Share change
-
+157,261
-
Total reported value
-
$3,034,000
-
Price per share
-
$6.45
-
Number of holders
-
19
-
Value change
-
+$2,076,284
-
Number of buys
-
13
-
Number of sells
-
4
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2018
As of 30 Sep 2018,
IGC Pharma, Inc. - COM NEW (IGC) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
472,561 shares.
The largest 10 holders included
Carroll Financial Associates, Inc., Creative Planning, HSBC HOLDINGS PLC, SUNTRUST BANKS INC, JANE STREET GROUP, LLC, ING GROEP NV, Cambridge Investment Research Advisors, Inc., CenterStar Asset Management, LLC, Advisor Group, Inc., and LADENBURG THALMANN FINANCIAL SERVICES INC..
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.